Target intelligence / Profile preview

MicroRNA 489 (miR-489)

Target
miR-489
Molecular classification
MicroRNA, Non-coding RNA, miRNA class
01

Overview

MicroRNA 489 (miR-489) is a highly conserved small non-coding RNA (miRNA) within the mammalian genome and is primarily involved in post-transcriptional gene regulation by binding to mRNA targets, resulting in their degradation or translational inhibition. It is transcribed from an intron within the CALCR (calcitonin receptor) gene. MiR-489 plays important biological roles, notably maintaining muscle stem cell (satellite cell) quiescence by suppressing the oncogene DEK, and acting as a tumor suppressor in several cancers—including breast, head and neck, and kidney—by targeting oncogenes such as HER2 (ERBB2), PTPN11 (SHP2), and HDAC2, thereby regulating cell proliferation, survival, and differentiation. Downregulation of miR-489 is associated with increased cell proliferation and tumor progression, while its restoration or overexpression can inhibit cancer cell growth and may serve as a potential therapeutic approach. It also plays a role in the inhibition of cardiac fibroblast proliferation and fibrosis. The expression pattern of miR-489 and its targets makes it a biomarker candidate for patient stratification and prognosis in oncology.

Other names
hsa-mir-489MIRN489MIR489mir-489
02

Mechanism of action

Post-transcriptional inhibition of target oncogenes such as DEK, HER2/ERBB2, PTPN11 (SHP2), HDAC2, etc. Down-regulation of oncogenic signaling pathways including HER2-SHP2-MAPK.

03

Biological functions

Post-transcriptional gene regulationMaintenance of stem cell quiescenceSuppression of cell proliferationInhibition of differentiation in cardiac fibroblasts
04

Disease associations

Cancer (e.g., breast cancer, hypopharynx cancer, kidney cancer, head and neck squamous cell carcinoma)Cardiovascular disease (specifically cardiac fibrosis)
05

Safety considerations

Potential impairment of tissue regeneration if overexpressed, due to its maintenance of stem cell quiescence and proliferation inhibitionGeneral risks associated with manipulating miRNA pathways, such as off-target effects and complex regulation
06

Biomarkers

miR-489 expression level as a prognostic or diagnostic marker in breast cancer and other cancers

Beyond the preview

Go deeper on MicroRNA 489 (miR-489).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 489 (miR-489).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call